SEC Form 4 · accession 0001638599-17-000105
Fortress Biotech, Inc. · FBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jimmie Harvey
Director
Period of report
Jan 1, 2017
Accepted (ET)
Jan 24, 2017 · 6:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001429260
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 | holding | — | — | — | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Restricted Stock UnitsF2,F1 | $0.00 | Jan 1, 2017 | A | 16,666 | A | — | — | Common Stock | 16,666 | 33,332 | D |
| Deferred Restricted Stock UnitsF2,F3 | $0.00 | Jan 1, 2017 | A | 16,666 | A | — | — | Common Stock | 16,666 | 33,332 | D |
| Options to purchase Common StockF4 | $1.37 | holding | — | — | — | — | Oct 5, 2020 | Common Stock | 25,000 | 25,000 | D |
| Options to purchase Common StockF5 | $6.25 | holding | — | — | — | — | Feb 10, 2022 | Common Stock | 15,000 | 15,000 | D |
| Options to purchase Common StockF6 | $7.42 | holding | — | — | — | — | Feb 7, 2023 | Common Stock | 15,000 | 15,000 | D |
| Options to purchase Common StockF7 | $2.10 | holding | — | — | — | — | Dec 19, 2023 | Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The Reporting Person was granted restricted stock units ("RSUs") for service as a director in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.
- F2Upon the vesting of RSUs, the Reporting Person deferred the receipt of 16,666 shares of common stock and received instead 16,666 shares of deferred RSUs.
- F3The Reporting Person was granted RSUs for service on the Strategic Transaction Committee in 2016, vesting one-third annually beginning on January 1, 2017. The Reporting Person deferred receipt of all the common stock upon the vesting of the RSUs under the Plan. Each deferred RSU that has vested will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.
- F4One-third of the shares vested on each of October 5, 2011, 2012 and 2013.
- F5One-third of the shares vested on each of February 10, 2013, 2014 and 2015.
- F6One-third of the shares vested on each of February 7, 2014, 2015 and 2016.
- F7One-third of the shares vested on each of December 19, 2014, 2015 and 2016.